Evidence map›Paper›PMID 31738556›Full record

ArticleThe Journal of organic chemistry2019

Sequential Xanthalation and

Makoto Yoritate, Allyn T Londregan, Yajing Lian, John F Hartwig

Open access · greenAbstract read
In one paragraph

Article in The Journal of organic chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Trifluoromethoxypyrazines: Preparation and Properties.Molecules (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Makoto YoritateDepartment of Chemistry , University of California , Berkeley , California 94720 , United States.ORCID 0000-0003-2182-3914
Allyn T LondreganMedicine Design , Pfizer Inc. , Groton , Connecticut 06340 , United States.ORCID 0000-0001-8832-340X
Yajing LianMedicine Design , Pfizer Inc. , Groton , Connecticut 06340 , United States.
John F HartwigDepartment of Chemistry , University of California , Berkeley , California 94720 , United States.ORCID 0000-0002-4157-468X
Pfizer (United States) · USUniversity of California, Berkeley · US

Funding

Discovery and Development of Organic Reactions Catalyzed by Transition Metals Valuable for Medicinal ChemistryR35GM130387 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI John F Hartwig · 2019 to 2026
$7.1M
NIGMS NIH HHS R35 GM130387
6 · The paper itself

Abstract

Molecules containing trifluoromethoxyaryl groups are of interest in pharmaceutical, agrochemical, and materials science research, due to their unique physical and electronic properties. Many of the known methods to synthesize aryl trifluoromethyl ethers require harsh reagents and highly controlled reaction conditions and rarely occur when heteroaromatic units are present. The two-step

Indexed as

EthersHydrocarbons, FluorinatedMolecular StructurePhenolsXanthinesEthersHydrocarbons, FluorinatedPhenolsXanthines

Identifiers

PMID31738556
PMCPMC7660230
OpenAlexW2983271205

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.